
-
2007
Company Description
TaiMed Biologics offers Ibalizumab, a monoclonal antibody and a member of HIV viral-entry inhibitor therapy.
TaiMed Biologics Inc. operates as a biotechnology company. The company develops Ibalizumab, a monoclonal Antibody (mAb) and a member of HIV viral-entry inhibitor therapy. TaiMed Biologics Inc. was founded in 2007 and is based in Taipei, Taiwan.
-
Manufacturer:
Data and Analytics -
Formed:
2007 -
Founders:
David Ho -
Company Website:
-
Company E-mail:
-
Company Address:
Room E1803 18th Floor, No 3 Yuan-Qu Street Nangang DistrictTaipeiTaiwan -
CEO:
- David Ho
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits